These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 840203)

  • 41. Zinc status in patients with major beta-thalassemia.
    Mehdizadeh M; Zamani G; Tabatabaee S
    Pediatr Hematol Oncol; 2008; 25(1):49-54. PubMed ID: 18231954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Auxologic studies on acceleration of growth and on definitive body height].
    Tatafiore E
    Minerva Pediatr; 1965 Jul; 17(21):1148-51. PubMed ID: 5834027
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical presentation of thalassemia major due to homozygous beta (0)-thalassemia.
    Galanello R; Cossu P; Pirastu M; Cao A
    Nouv Rev Fr Hematol (1978); 1981; 23(2):101-6. PubMed ID: 7290983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Beta-thalassemia major in children and adolescents in Denmark].
    Jung A; Main KM; Scheibel E; Peitersen B; Clausen N; Erichsen G; Schmiegelow K; Illum N
    Ugeskr Laeger; 2002 Dec; 164(49):5803-6. PubMed ID: 12523224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Development of body height and weight of Czech and Slovak children during the seventies].
    Hajnis K; Blazek V; Brůzek J; Hajnisová A
    Cesk Pediatr; 1983 Dec; 38(12):737-43. PubMed ID: 6661796
    [No Abstract]   [Full Text] [Related]  

  • 46. Allogeneic marrow transplantation for thalassemia.
    Lucarelli G; Polchi P; Izzi T; Manna M; Agostinelli F; Delfini C; Porcellini A; Galimberti M; Moretti L; Manna A
    Exp Hematol; 1984 Sep; 12(8):676-81. PubMed ID: 6386507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Investigation of immunoconglutinin in beta-thalassemic patients after multiple transfusions].
    Govoni F; Govoni M
    Riv Emoter Immunoematol; 1983; 30(3):282-7. PubMed ID: 6669877
    [No Abstract]   [Full Text] [Related]  

  • 48. [Neurologic pathology in subjects with beta-thalassemia major].
    Incorpora G; Romeo MA; Inì G; Pizzarelli G; Di Gregorio F
    Minerva Pediatr; 1988 Jan; 40(1):41-6. PubMed ID: 3374452
    [No Abstract]   [Full Text] [Related]  

  • 49. [Value of height-weight growth curves].
    Savary A
    Rev Med Suisse Romande; 1998 May; 118(5):483-6. PubMed ID: 9673496
    [No Abstract]   [Full Text] [Related]  

  • 50. Growth in homozygous beta-thalassemia after bone marrow transplantation.
    Ponte G; Ferrara M; Esposito L
    Bone Marrow Transplant; 1991; 8 Suppl 1():68-9. PubMed ID: 1760650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Somatogram. Age-height-weight relations].
    Kunze D
    Fortschr Med; 1977 Mar; 95(9):548-9. PubMed ID: 844781
    [No Abstract]   [Full Text] [Related]  

  • 52. Colloid clearance rate changes in children with homozygous-beta-thalassemia in relation to blood transfusion.
    Dimitriou PA; Karpathios TE; Antipas SE; Fretzayias AM; Kasfiki AG; Melissinos KG; Matsaniotis NS
    Eur J Nucl Med; 1980 Oct; 5(5):427-30. PubMed ID: 7215364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Height-weight growth of cleft children, birth to six years.
    Ranalli DN; Mazaheri M
    Cleft Palate J; 1975 Oct; 12():400-4. PubMed ID: 1058750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth and endocrine function after bone marrow transplantation for thalassemia major.
    Manenti F; Galimberti M; Lucarelli G; Polchi P; De Sanctis V; Tanas R; Vullo C; Ruggiero L
    Prog Clin Biol Res; 1989; 309():273-80. PubMed ID: 2675095
    [No Abstract]   [Full Text] [Related]  

  • 55. [Incidence of Australia antigen (HB Ag) and its related antibody (HB Ab) in Siciliam thalassemic children treated with multiple transfusions].
    Musumeci S; Di Gregorio F; Marino S; Fischer A; Pizzarelli G
    Pediatria (Napoli); 1977 Mar; 85(1):21-33. PubMed ID: 876745
    [No Abstract]   [Full Text] [Related]  

  • 56. [Long-term results of splenectomy in thalassemia major].
    Alamanni F; Gallisai D; Maniga AM; Bacciu PP; Noya G; Frassetto GA; Dettori G; Biglioli P
    Minerva Chir; 1983 May; 38(10):693-6. PubMed ID: 6877629
    [No Abstract]   [Full Text] [Related]  

  • 57. Management of thalassemia: a comparative program.
    Wolff JA; Luke KH
    Ann N Y Acad Sci; 1969 Nov; 165(1):423-6. PubMed ID: 5260164
    [No Abstract]   [Full Text] [Related]  

  • 58. Physical growth parameters in thalassemic children.
    George A; Bhaduri A; Sen S; Choudhry VP
    Indian J Pediatr; 1997; 64(6):861-71. PubMed ID: 10771931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variation in Transfusion Requirements Among Children With Thalassemia on Regular Transfusion Programs: Which Formula Closely Predicts the Actual Requirements?
    Cornell N; Eisenhut M; Ramprakash S
    J Pediatr Hematol Oncol; 2017 Oct; 39(7):e388-e390. PubMed ID: 28060132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [EFFECTS OF SPLENECTOMY ON STATURE AND WEIGHT INCREASE AND SKELETAL AGE IN THALASSEMICS].
    LOJACONO F; ARCARA G; BELLISA A
    Clin Pediatr (Bologna); 1963 Jul; 45():459-82. PubMed ID: 14111829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.